Laminin-1 is a major component and multifunctional
glycoprotein of basement membranes that consists of three different subunits, alpha1, beta1 and gamma11 chains. It is the earliest synthesized network-forming
protein during embryogenesis and plays an important role in embryonic development, embryonic implantation and placentation. We have recently shown that
IgG anti-laminin-1
antibodies were significantly associated with recurrent first-trimester
miscarriages and with subsequent pregnancy outcome. Interestingly, these
antibodies were also observed in patients with
endometriosis-associated
infertility but not in patients with other causes of
infertility, including tubal factors, hormonal and uterine abnormalities. Laminin-alpha1, -beta1 and -gamma1 mRNAs have been detected in 90% of endometriotic lesions and all laminin-alpha1, -beta1 and -gamma1 chains were localized in the basement membranes of glandular epithelium in endometriotic peritoneal lesions. Western blot analysis showed that anti-laminin-1
antibodies from those patients reacted with all laminin-1's chains. ELISA also confirmed that one of the target
epitopes for these
antibodies was located in a particular region of the
laminin-1 molecule, i.e. the carboxyl-terminal globular G domain of alpha1 chain.
IgM monoclonal anti-laminin-1
autoantibody, that we recently established, also recognized the G domain. Anti-laminin-1
antibodies from mice immunized with "mouse"
laminin-1, caused a higher
fetal resorption rate with lower embryonic and placental weights. Thus, anti-laminin-1
antibodies may be important in development of autoimmune-mediated reproductive failures and the assessment of the
antibodies may provide a novel non-invasive diagnosis of
endometriosis.